This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,411 Years Active: 2001
Title: Michio Shimabukuro: Innovator in Diabetes Treatment
Introduction
Michio Shimabukuro is a notable inventor based in Okinawa, Japan. He has made significant contributions to the field of diabetes treatment through his innovative research and patented methods. His work focuses on the role of free radicals in the treatment and prevention of diabetes.
Latest Patents
Shimabukuro holds a patent for "Methods and compositions relating to no-mediated cytotoxicity." This invention addresses the treatment of diabetes by demonstrating that manganese superoxide dismutase (MnSOD) can protect against cytokine-induced cell death. The patent outlines strategies for engineering cell lines to serve as islet surrogates for transplantation therapy in diabetes mellitus. Additionally, it highlights the role of fatty acids in mediating β-cell destruction and dysfunction in adipogenic diabetes, providing methods and compositions to ameliorate this disorder. He has 1 patent to his name.
Career Highlights
Throughout his career, Shimabukuro has focused on innovative approaches to diabetes treatment. His research has contributed to a deeper understanding of the mechanisms involved in diabetes and has paved the way for new therapeutic strategies.
Collaborations
Shimabukuro has collaborated with notable colleagues, including Anice E Thigpen and Guoxun Chen. Their combined expertise has further advanced the research in diabetes treatment and related fields.
Conclusion
Michio Shimabukuro's work in diabetes treatment exemplifies the impact of innovative research on healthcare. His patented methods and compositions offer promising avenues for improving the lives of those affected by diabetes.